Biotech Company, OmniPulse is making strides toward vaccine delivery, backed by grants from the Bill & Melinda Gates Foundation.

OmniPulse Biosciences, a pioneering biotech company, is making strides toward accessible healthcare with a novel approach to vaccine delivery. Backed by a recent grant from the Bill & Melinda Gates Foundation, this groundbreaking innovation allows for a single-injection solution designed to deliver medication over an extended period, aiming to transform treatments across both developing as well as developed countries.

This unique, multi-layered polymer system gradually releases drugs, providing a sustained treatment option with a single injection and improving adherence to therapies. This effort marks a critical step in bringing sustainable healthcare to a massively underserved market. OmniPulse hopes to reshape global health outcomes.

Submit Your Company Deck:
[email protected]
Work with us:
[email protected]

SHARE